Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093054 · ClinicalTrials.gov registry record · Phase 2
Cranberry Juice for Treatment of Urinary Tract Infections
A Phase 2 study of Urinary Tract Infections, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 319
- Enrollment target
- 1
- Study location
NCT00093054: Completed Phase 2 study of Urinary Tract Infections, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00093054 is a Phase 2 study of Urinary Tract Infections that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 319 participants, below the 449-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00093054, a Phase 2 study of Urinary Tract Infections, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 319 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether daily consumption of cranberry juice lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This study will also determine whether drinking cranberry juice for 6 months selects for less virulent bacteria in the rectal, vaginal, and urethral areas.
Conditions Studied
Interventions
- DRUG Cranberry juice
- DIETARY_SUPPLEMENT Placebo cranberry juice
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2004-11 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
What the finished NCT00093054 record still lists
NCT00093054 is an interventional study that assigns participants to a tested intervention. The registered 319 participants enrollment target is mid-sized for trials with a published cap, below the 449-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Cranberry juice is the first listed.
NCT00093054 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00093054 about?
NCT00093054 is a clinical study titled "Cranberry Juice for Treatment of Urinary Tract Infections". The purpose of this study is to determine whether daily consumption of cranberry juice lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This study will also determine whether drinking cranberry juice for 6 months selects for less virulent bacteria in the rectal, v...
What is the current status of trial NCT00093054?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 319 participants. The study started on 2004-11. Estimated completion is 2009-12.
What conditions does trial NCT00093054 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT00093054?
The interventions under investigation include: Cranberry juice (DRUG), Placebo cranberry juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00093054?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00093054 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00093054's enrollment target sits among peer trials
319 13th of 34 higher than 22 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
-
UTI Prophylaxis Using Bacterial Interference Following SCI
COMPLETED · Phase 2
-
Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections
COMPLETED · Phase 2
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05377996 · 319 participants · Phase 1
A Study of XMT-1660 in Participants With Solid Tumors
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia